Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mader

Showing results (141-150 of 221) with videos related to

Pageof 23
Sort By:
The Journal of Laboratory and Clinical Medicine|June 1, 2001
Reverse transcriptase template switching during reverse transcriptase-polymerase chain reaction: artificial generation of deletions in ribonucleotide reductase mRNAR M Mader, W M Schmidt, R Sedivy, et al.
Cancer|October 12, 2001
Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanomaC Joukhadar, N Klein, R M Mader, et al.
British Journal of Cancer|October 31, 2013
Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complexB Giessrigl, W M Schmidt, M Kalipciyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Her2 and progesterone receptor status are not predictive of response to fulvestrant treatmentRupert Bartsch, Catharina Wenzel, Gabriela Altorjai, et al.
Wiener Klinische Wochenschrift|March 20, 2004
Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancerSusanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinomaG G Steger, M F Gnant, M P Djavanmard, et al.
Scientific Reports|March 18, 2020
Initial pupil status is a strong predictor for in-hospital mortality after aneurysmal subarachnoid hemorrhageMarius M Mader, Andras Piffko, Nora F Dengler, et al.
Cancer Research|July 1, 1997
5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patientsM Müller, R M Mader, B Steiner, et al.
Metallomics : Integrated Biometal Science|February 10, 2015
Extravasation of Pt-based chemotherapeutics - bioimaging of their distribution in resectates using laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS)Alexander E Egger, Christoph Kornauth, Werner Haslik, et al.
Journal of Medical Entomology|July 16, 2021
A Survey of Tick Surveillance and Control Practices in the United StatesEmily M Mader, Claudia Ganser, Annie Geiger, et al.
Pageof 23

Showing results (141-150 of 221) with videos related to

Sort By:
Pageof 23
The Journal of Laboratory and Clinical Medicine|June 1, 2001
Reverse transcriptase template switching during reverse transcriptase-polymerase chain reaction: artificial generation of deletions in ribonucleotide reductase mRNAR M Mader, W M Schmidt, R Sedivy, et al.
Cancer|October 12, 2001
Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanomaC Joukhadar, N Klein, R M Mader, et al.
British Journal of Cancer|October 31, 2013
Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complexB Giessrigl, W M Schmidt, M Kalipciyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Her2 and progesterone receptor status are not predictive of response to fulvestrant treatmentRupert Bartsch, Catharina Wenzel, Gabriela Altorjai, et al.
Wiener Klinische Wochenschrift|March 20, 2004
Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancerSusanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinomaG G Steger, M F Gnant, M P Djavanmard, et al.
Scientific Reports|March 18, 2020
Initial pupil status is a strong predictor for in-hospital mortality after aneurysmal subarachnoid hemorrhageMarius M Mader, Andras Piffko, Nora F Dengler, et al.
Cancer Research|July 1, 1997
5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patientsM Müller, R M Mader, B Steiner, et al.
Metallomics : Integrated Biometal Science|February 10, 2015
Extravasation of Pt-based chemotherapeutics - bioimaging of their distribution in resectates using laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS)Alexander E Egger, Christoph Kornauth, Werner Haslik, et al.
Journal of Medical Entomology|July 16, 2021
A Survey of Tick Surveillance and Control Practices in the United StatesEmily M Mader, Claudia Ganser, Annie Geiger, et al.
Pageof 23